We are committed to provide best-in-class technology to help clinicians accurately diagnose
Our goal is to help radiologists, surgeons and clinicians around the world make the breast cancer diagnostics process quicker, easier and better.
Our Mission & Vision
Advancing Cancer Diagnostics, Improving Lives
Enabling clinicians to efficiently provide patients a highly confident diagnosis within 24-hours from biopsy
We will achieve this goal through our commitment to innovation, quality and education.
Our Core Values
It Begins With Us
Employees are our most valuable asset.
We are committed to their growth
and development.
We Work to Improve
Every Day
We encourage a culture of
continuous improvement.
We Deliver Results
Our brands empower our growth.
We are the partner of choice.
Our Priority is the
Patient’s Experience
We focus on providing high
quality products.
Innovate for Today
and Tomorrow
We find ways to get better results through
current and new technologies.
OUR PAST
In 1995, Mammotome was introduced as the first vacuum-assisted biopsy system. Two years later, the Mammotome Biopsy System was acquired by Ethicon Endo-Surgery (EES), part of the Johnson & Johnson Family of Companies. EES continued to develop the Mammotome Biopsy System, creating additional image-guided products and developing the Mammotome brand into the worldwide market leader.
In July 2010, Devicor Medical Products, Inc. acquired the Breast Care Business from Ethicon Endo-Surgery. Devicor focuses exclusively on medical technologies that improve patient experiences and outcomes. Over the next several years, Devicor Medical launched two new innovative vacuum-assisted breast biopsy systems and acquired several other products to create a robust breast care product portfolio.
OUR FUTURE
In December 2014, Devicor Medical Products was acquired by Leica Biosystems, part of the Danaher family of companies. Leica Biosystems is the global leader in anatomic pathology solutions and automation, striving to advance cancer diagnostics to improve patients’ lives. The combination of the two companies uniquely positions us to develop integrated patient-to-pathology solutions for the diagnosis of cancer.
Headquartered in Cincinnati, Ohio, the Mammotome brand is sold in over 50 different countries throughout the world. Mammotome remains committed to its heritage of advancing technology for early detection of breast cancer, providing support and education for clinicians worldwide, and offering breast care information for patients.
To date, more than 5 million women worldwide have had a procedure using the minimally invasive Mammotome Biopsy System.
Vision 24
Enabling clinicians to efficiently provide patients a highly confident diagnosis within 24-hours from biopsy.
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
In line with our Mission, we have established the following challenge for ourselves: Enable patients to get their diagnosis within 24 hours from biopsy. This is a goal we are striving towards, a goal that will guide our future strategies. This vision aims to decrease the time it takes from biopsy to patient diagnosis, to a 24 hour period. With a presence in every step of the workflow, no other company is positioned to streamline all these steps so that the whole process takes less than 24 hours.
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Danaher is a global science and technology innovator committed to helping customers solve complex challenges and improving quality of life around the world. Our trusted brands hold unparalleled leadership positions in diagnostics, life sciences, dental and environmental and applied solutions. With more than 30 operating companies, our globally diverse team of 59,000 associates is united by a shared purpose: to help realize life’s potential.
